Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000886982-25-001471
Filing Date
2025-11-12
Accepted
2025-11-12 15:55:19
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 9487
2 POA13G-20820635_20251008.txt EX-99 5547
  Complete submission text file 0000886982-25-001471.txt   16900
Mailing Address 200 WEST STREET NEW YORK NY 10282
Business Address 200 WEST STREET NEW YORK NY 10282 212-902-1000
GOLDMAN SACHS GROUP INC (Filed by) CIK: 0000886982 (see all company filings)

EIN.: 134019460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G
SIC: 6211 Security Brokers, Dealers & Flotation Companies
(CF Office: 02 Finance)

Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Subject) CIK: 0001652130 (see all company filings)

EIN.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-89486 | Film No.: 251472317
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)